We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response.
- Authors
Fisher, Carla S; Ma, Cynthia X; Gillanders, William E; Aft, Rebecca L; Eberlein, Timothy J; Gao, Feng; Margenthaler, Julie A
- Abstract
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that is known to be chemosensitive. In patients with TNBC, we sought to compare survival outcomes between patients receiving neoadjuvant chemotherapy, with and without complete pathologic response (pCR), and those receiving adjuvant chemotherapy.
- Publication
Annals of surgical oncology, 2012, Vol 19, Issue 1, p253
- ISSN
1534-4681
- Publication type
Journal Article
- DOI
10.1245/s10434-011-1877-y